Biodexa Pharmaceuticals (BDRX) Invested Capital (2013 - 2025)
Biodexa Pharmaceuticals (BDRX) reported Invested Capital of $15.25 million for the quarter ended Dec 31, 2025, up 31.3% from $11.61 million a year earlier.
Powered by 
Analysis
Biodexa Pharmaceuticals (BDRX) Invested Capital (2013 - 2025) Analysis & Trends
For the year ended Dec 31, 2025, Biodexa Pharmaceuticals posted Invested Capital of $15.12 million, up 30.7% from the prior year.
- Invested Capital has increased for three consecutive years, with a five-year compound annual growth rate of 11.0% (years ended Dec 2020 to Dec 2025).
- By year, Invested Capital came in at $11.57 million in the year ended Dec 31, 2024 (+80.9%), $6.4 million in the year ended Dec 31, 2023 (+36.5%), $4.69 million in the year ended Dec 31, 2022 (-69.6%) and $15.43 million in the year ended Dec 31, 2021 (+72.2%).
- Five-year quarterly Invested Capital spans a low of $4.44 million in the quarter ended Dec 31, 2022 and a high of $15.92 million in the quarter ended Jun 30, 2025.
- The high point for year-over-year Invested Capital in five years was the quarter ended Dec 31, 2024 (growth of 82.0%); the low point was the quarter ended Dec 31, 2022 (a decline of 70.6%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 134.01 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 64.89 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 95.89 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 79.44 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.26 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 68.99 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 38.08 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 148.69 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Biodexa Pharmaceuticals | 41.69 Mn | 18.48 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 15.25 Mn |
| Jun 30, 2025 | 15.92 Mn |
| Dec 31, 2024 | 11.61 Mn |
| Jun 30, 2024 | 11.50 Mn |
| Dec 31, 2023 | 6.38 Mn |
| Jun 30, 2023 | 7.31 Mn |
| Dec 31, 2022 | 4.44 Mn |
| Jun 30, 2022 | 10.33 Mn |
| Dec 31, 2021 | 15.12 Mn |
| Jun 30, 2021 | 6.38 Mn |
| Dec 31, 2020 | 9.21 Mn |
| Jun 30, 2020 | 10.00 Mn |
| Dec 31, 2019 | 32.97 Mn |
| Jun 30, 2019 | 33.25 Mn |
| Dec 31, 2018 | 23.39 Mn |
| Jun 30, 2018 | 40.95 Mn |
| Dec 31, 2017 | 54.74 Mn |
| Jun 30, 2017 | 49.31 Mn |
| Dec 31, 2016 | 59.53 Mn |
| Jun 30, 2016 | 61.08 Mn |
API Access
Biodexa Pharmaceuticals Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=BDRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "BDRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=BDRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();